The FDA has approved Voranigo to treat certain patients with grade 2 astrocytoma or oligodendroglioma with select mutations, following surgery. The Food and Drug Administration (FDA) has approved ...

Pediatric low-grade gliomas (pLGGs) exhibit distinct biological and clinical characteristics compared to adult gliomas, and their treatment strategies differ substantially from those used in adults.

Please provide your email address to receive an email when new articles are posted on . Maximal resection of low-grade glioma shortly after diagnosis may lead to longer survival, according to research ...

A recent reclassification of brain tumors based on molecular subtypes has led to questions over whether extensive surgery is the best approach for some tumor types or whether chemoradiotherapy may be ...

The transition of a low-grade, slow growing brain tumor to a lethal one can be delayed if neurosur-geons remove as much as possible soon after diagnosis, according to the results of a new study. The ...